Clinical Trial Update: Efficacy of Topical 95% TCA in the Treatment of CIN 1 or Less After Low-grade Abnormality of Screening Test [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating topical 95% trichloroacetic acid for CIN1 or less after low-grade screening abnormalities has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Trichloroacetic acid, topical (trichloroacetic acid)

Snippet

Sponsor: Department of Medical Services Ministry of Public Health of Thailand | Conditions: CIN1, Trichloroacetic Acid | Phase 2, Phase 3 | Status: WITHDRAWN